(Q53796285)

19 May 2018

title

Immunopotentiation of Staphylococcus aureus type 5 capsular polysaccharide co-entrapped in liposomes with alpha-toxin. (English)

1 reference

19 May 2018

1 reference

Staphylococcus aureus

1 reference

Burgeot C

1

1 reference

19 May 2018

Gilbert FB

series ordinal

2

1 reference

19 May 2018

Poutrel B

series ordinal

3

1 reference

19 May 2018

language of work or name

English

0 references

publication date

1 February 2001

1 reference

19 May 2018

published in

Vaccine

1 reference

19 May 2018

volume

19

1 reference

19 May 2018

issue

15-16

1 reference

19 May 2018

page(s)

2092-2099

1 reference

19 May 2018

Staphylococcus aureus: a well-armed pathogen

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Immunogenicity in cows of Staphylococcus aureus type 5 capsular polysaccharide-ovalbumin conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Immune recruitment and bactericidal activity of neutrophils in milk of cows vaccinated with staphylococcal alpha-toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Immunological adjuvants: a role for liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

The immunological adjuvant and vaccine carrier properties of liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Use of liposome-immunopotentiated exopolysaccharide as a component of an ovine mastitis staphylococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Isolation of type 5 capsular polysaccharide from Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Preparation and purification of staphylococcal alpha toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Subunit stoichiometry of staphylococcal alpha-hemolysin in crystals and on membranes: a heptameric transmembrane pore

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Molecular biology of the pore-forming cytolysins from Staphylococcus aureus, alpha- and gamma-hemolysins and leukocidin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Pore formation by S. aureus alpha-toxin in liposomes and planar lipid bilayers: effects of nonelectrolytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Liposomes as carriers for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Liposomes as carriers of antigens and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Peptide vaccines based on enhanced immunogenicity of peptide epitopes presented with T-cell determinants or hepatitis B core protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900402-3

7 January 2021

10.1016/S0264-410X(00)00402-3

Identifiers

DOI

1 reference

19 May 2018

1 reference

19 May 2018